Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness model age related macular degeneration comparing macugen visudyne
… use increased among both younger patients and those over age 65. This study demonstrates a substantial increase in …
… achieve better health outcomes. Research can lead the way. Related Services Health Economics Staff Members Mark Price …
… antipsychotics in patients with Parkinson's disease–related psychosis. Layton JB, McQuay L, Forns J, Danysh HE, …
… oral pre-exposure prophylaxis (PrEP) on HIV incidence and cost outcomes in the United States. Khurana N, Hicks KA, …
… Meaningful Work From understanding the cost-effectiveness of treatments to helping reduce risks to …
Identifying Psychosis in Patients with Dementia Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the Challenge Really Exists Joan Forns , J Bradley Layton , and Mary E Ritchey Transcript: Psychosis is a common …
… methods such as literature reviews and distributional cost-effectiveness analysis Review social determinants data and …
… a partially observable Markov decision process (POMDP) model that maximizes quality-adjusted life-years (QALYs) … University Press; 2022. p.141-58. ISBN: 9781108836739 Related Services Health Economics Staff Members Christine …
… intervals. Read the full research at this link . Related Services Pharmacoepidemiology and Risk Management …
HTA and Reimbursement Considerations for Orphan Drugs in European Markets HTA and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers? Heyes A, McBride D, Pearson I, Copley-Merriman C …